Clovis Oncology, Inc.

GOLDMAN SACHS GROUP INC

Report date

9/30/2022

Quarter

2022 Q3

Filed

5/14/2024

Shares

139,904

Value ($000)

166

Weight

0.0%

2013 Q4 - 2022 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	5/14/2024	166	0.0%	139,904	9/30/2022
2022 Q2	5/14/2024	435	0.0%	241,621	6/30/2022
2022 Q1	5/16/2022	600	0.0%	297,021	3/31/2022
2021 Q4	2/17/2022	1,340	0.0%	494,457	12/31/2021
2021 Q3	1/20/2022	2,247	0.0%	503,752	9/30/2021
2021 Q2	8/13/2021	2,094	0.0%	361,026	6/30/2021
2021 Q1	5/17/2021	3,757	0.0%	535,149	3/31/2021
2020 Q4	2/12/2021	2,094	0.0%	436,199	12/31/2020
2020 Q3	11/13/2020	1,754	0.0%	300,872	9/30/2020
2020 Q2	8/12/2020	1,141	0.0%	168,984	6/30/2020
2020 Q1	5/15/2020	8,530	0.0%	1,341,193	3/31/2020
2019 Q4	2/14/2020	3,824	0.0%	366,802	12/31/2019
2014 Q1	5/15/2014	15,822	0.0%	228,418	3/31/2014
2013 Q4	2/14/2014	7,365	0.0%	122,198	12/31/2013